FabRx

FabRx was founded by academics from University College London (UCL) who are passionate about using 3D printing technology to develop better medicines. FabRx envisions a world where medications can be produced on-site at pharmacies or clinical trial units tailored to each patient’s individual needs in terms of dosage, shape, size, and combination of doses. This makes taking medication easier and more effective.Established in 2014, FabRx is a small startup with big ambitions. Using their patented technology, FabRx provides a novel and flexible platform for the production of personalized medicines, offering revolutionary healthcare solutions to patients worldwide. The future of medicine is 3D.